mTOR Inhibitors: a myth, a cure for cancer or something in between?

G Wong; J R Chapman; J C Craig

doi:10.1111/j.1600-6143.2012.04007.x

mTOR Inhibitors: a myth, a cure for cancer or something in between?

G Wong, J R Chapman, J C Craig

Flinders University

Research output: Contribution to journal › Editorial

3 Citations (Scopus)

Abstract

This editorial summarizes the current evidence and the authors' perspective regarding the role of mTOR inhibitors and cancer in kidney transplant recipients. See article by Campbell et al on page 1146.

Original language	English
Pages (from-to)	1075-1076
Number of pages	2
Journal	American Journal of Transplantation
Volume	12
Issue number	5
DOIs	https://doi.org/10.1111/j.1600-6143.2012.04007.x
Publication status	Published - May 2012

Keywords

cancer
kidney transplantation
Mammalian target of rapamycin (mTOR) inhibitors

Access to Document

10.1111/j.1600-6143.2012.04007.xLicence: In Copyright

Cite this

@article{9f9fb076335f471d8383669538aab711,

title = "mTOR Inhibitors: a myth, a cure for cancer or something in between?",

abstract = "This editorial summarizes the current evidence and the authors' perspective regarding the role of mTOR inhibitors and cancer in kidney transplant recipients. See article by Campbell et al on page 1146.",

keywords = "cancer, kidney transplantation, Mammalian target of rapamycin (mTOR) inhibitors",

author = "G Wong and Chapman, {J R} and Craig, {J C}",

year = "2012",

month = may,

doi = "10.1111/j.1600-6143.2012.04007.x",

language = "English",

volume = "12",

pages = "1075--1076",

journal = "American Journal of Transplantation",

issn = "1600-6135",

number = "5",

}

TY - JOUR

T1 - mTOR Inhibitors

T2 - a myth, a cure for cancer or something in between?

AU - Wong, G

AU - Chapman, J R

AU - Craig, J C

PY - 2012/5

Y1 - 2012/5

N2 - This editorial summarizes the current evidence and the authors' perspective regarding the role of mTOR inhibitors and cancer in kidney transplant recipients. See article by Campbell et al on page 1146.

AB - This editorial summarizes the current evidence and the authors' perspective regarding the role of mTOR inhibitors and cancer in kidney transplant recipients. See article by Campbell et al on page 1146.

KW - cancer

KW - kidney transplantation

KW - Mammalian target of rapamycin (mTOR) inhibitors

UR - http://www.scopus.com/inward/record.url?scp=84860453502&partnerID=8YFLogxK

U2 - 10.1111/j.1600-6143.2012.04007.x

DO - 10.1111/j.1600-6143.2012.04007.x

M3 - Editorial

SN - 1600-6135

VL - 12

SP - 1075

EP - 1076

JO - American Journal of Transplantation

JF - American Journal of Transplantation

IS - 5

ER -

mTOR Inhibitors: a myth, a cure for cancer or something in between?

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this